The prevalence of multidrug resistance (MDR) among gram-negative bacilli is increasing substantially [1] [2] [3] [4] . Compared with infections due to antimicrobial-susceptible gram-negative bacilli, infections due to MDR gram-negative bacilli (MDR-GNB) lead to worse outcomes, including longer hospital stays, increased mortality, and greater costs of hospitalization [5] [6] [7] .
Although antimicrobial-resistant pathogens historically have been considered to be primarily nosocomial pathogens, it has now become evident that these pathogens have spread to other health care settings and into the community, resulting in an influx of patients who have antimicrobial-resistant pathogens isolated at hospital admission [8, 9] . The temporal trends in the prevalence of MDR-GNB isolates recovered at hospital admission are not known. Quantification of the proportion of patients who harbor MDR-GNB at hospital admission and identification of common coresistance patterns are important to delineate, because findings would assist in the selection of empirical antimicrobial therapy. Although previous studies have identified risk factors for harboring MDR-GNB during hospitalization [10] [11] [12] , risk factors for harboring MDR-GNB at hospital admission have not been elucidated. Identification of a subgroup of patients who have a high risk of harboring MDR-GNB at hospital admission would have important implications for patient care. A 6-year study was therefore performed at a tertiary care center, to further the understanding of the epidemiology of MDR-GNB at hospital admission.
METHODS
The Beth Israel Deaconess Medical Center (Boston, MA) is a 530-bed tertiary-care teaching hospital with 7 in-tensive care units (ICUs) and an average of 27,000 patient admissions per year. The clinical committee of investigation at the study institution approved the present study.
Definition of MDR. "MDR" was defined as resistance to at least 3 different antibiotic groups, as reported elsewhere [1] . Antibiotics were included in the present analysis if susceptibility testing had been performed for at least 80% of the isolates, and if the route of drug administration was predominantly intravenous, except for the fluoroquinolones. According to these criteria, MDR among Klebsiella species, Enterobacter cloacae, and Escherichia coli was defined as resistance to at least 3 of the following antimicrobial groups: third-or fourth-generation cephalosporins, aminoglycosides, fluoroquinolones, piperacillins, and ampicillin/sulbactam. MDR among Pseudomonas aeruginosa was defined as resistance to at least 3 of the following antimicrobial groups: cephalosporins (only ceftazidime or cefepime), aminoglycosides, fluoroquinolones, carbapenems, and piperacillins.
Species identification and drug susceptibility testing of isolates. Species identification and drug susceptibility testing of isolates were performed using the automated Vitek I system (bioMérieux Vitek). NCCLS guidelines were used to define antimicrobial susceptibility thresholds [13] .
MDR-GNB isolates recovered at hospital admission. Computerized microbiological records from 1 January 1998 through 31 December 2003 were reviewed. Patients who harbored MDR-GNB were defined as patients who had P. aeruginosa, E. coli, Klebsiella species, or E. cloacae isolates recovered from clinical cultures within the first 48 h after hospital admission. Only 1 isolate per patient per year was included in the present analysis. For analysis of the temporal trends in coresistance patterns, multiple isolates per year per patient were included if the drug susceptibility profile of the isolate differed for at least 1 antibiotic group under study.
Case-control study. "Case patients" were defined as patients who had MDR-GNB isolates recovered from clinical cultures within the first 24 h after hospital admission during the last 12 months (from 31 December 2002 through 31 December 2003) of the 6-year study. This criterion was established to limit the number of potential case patients included in the study. For patients who had MDR-GNB isolates recovered during 11 hospitalization, data from the first hospitalization were recorded. Control patients were selected from among all patients who were admitted to the hospital during the same period and who did not have MDR-GNB isolates recovered. Control patients were chosen according to use of the following algorithm: for each case patient, 1 control patient whose date of admission to the hospital was the same as that of a case patient was selected, according to the alphabetical order of the patient's last name.
Data collection. Computerized medical, pharmacy, and microbiological records were reviewed to collect patient data. The data obtained included information on patient residence before hospital admission, the number of hospitalizations that occurred in the previous year, and exposure to antibiotics within 90 days before inclusion in the study. The Charlson score was used to provide a composite score of comorbid conditions [14] . Exposure to antibiotics after hospital admission was assessed to determine whether antimicrobial therapy was "appropriate"; therapy was considered to be appropriate if the patient received at least 1 antibiotic with activity against the MDR-GNB isolate subsequently recovered from clinical cultures.
Infections were defined according to criteria outlined by the Centers for Disease Control and Prevention [15] . "Colonization" was defined as the recovery of MDR-GNB isolates from clinical cultures performed for patients without clinical signs and symptoms of infection.
Statistical analysis. Statistical analysis was performed using Stata software, version 7.0 (StataCorp). Categorical variables were analyzed using the test, and continuous variables were 2 x analyzed using the Student's t test or the Wilcoxon rank-sum test for nonparametric distributions. Duration of antibiotic exposure was dichotomized to a common course of therapy at 14 days. Variables found to be statistically significant on crude analysis ( ) were included in a stepwise logistic regression P р .05 model. Temporal trends of antimicrobial resistance were analyzed using the test for trend. The frequency of coresistance 2 x patterns was calculated by dividing the number of clinical isolates that exhibited a specific MDR pattern by the total number of MDR-GNB isolates for each species.
RESULTS

Prevalence of MDR-GNB isolates recovered at hospital admission.
The prevalence of MDR-GNB isolates recovered from patients within the first 48 h after hospital admission significantly increased for all 4 groups of MDR-GNB studied ( ), with P ! .001 the exception of P. aeruginosa ( ) ( figure 1 ). P p .09 Coresistance patterns. Of the 464 MDR-GNB isolates recovered, 12%, 35%, and 53% were coresistant to 5, 4, and 3 antimicrobials, respectively (table 1). Table 2 shows, for each species of MDR-GNB, the overall resistance to individual antimicrobial groups. The frequencies of specific coresistance patterns, stratified according to resistance to 3, 4, and 5 antimicrobial groups, for each species of MDR-GNB, are shown in figure 2 .
Risk factors for harboring MDR-GNB at hospital admission. A total of 55 case patients were included in the study. MDR E. coli, Klebsiella species, P. aeruginosa, and E. cloacae isolates were recovered from 47%, 22%, 18%, and 13% of case patients, respectively. Isolates were recovered from urine (55% of patients), blood (20% of patients), wound sites (15% of patients), sputum (4% of patients), and bile or peritoneal fluid (6% of patients).
Results of the crude analysis are shown in table 3. According to stepwise logistic regression, 3 variables were independently ). There was no significant interaction P ! .01 between the duration of prior exposure to antibiotics and residence in a long-term care facility.
Prior recurrent infections or colonization with other antimicrobial-resistant pathogens. Of the 110 case patients and control patients, 19 (17%) of the patients had a history of chronic skin ulcers, and 15 (14%) of the patients had a history of recurrent episodes of urinary tract infection (UTI). All 19 patients (100%) who had a history of chronic skin ulcers and 14 (93%) of the patients who had a history of recurrent episodes of UTI harbored MDR-GNB. The duration of prior antibiotic exposure was longer among patients with recurrent episodes of UTI or a history of chronic skin ulcers, compared with patients without these infections ( and , respectively). P p .05 P ! .001 A total of 12 case patients (22%) had a prior history of harboring methicillin-resistant Staphylococcus aureus (MRSA), and 4 case patients (7%) had a prior history of harboring vancomycin-resistant enterococci (VRE). Only 1 control patient (2%) had a prior history of harboring MRSA.
Infections due to MDR-GNB at hospital admission and appropriateness of antimicrobial therapy. Infection was documented in 44 (80%) of 55 case patients; among these 44 patients, UTI was documented in 50%; bacteremia, in 25%; decubitus ulcer, in 9%; intra-abdominal infection, in 9%; and surgical wound infection, in 7%. Eleven (20%) of the 55 case patients had colonization documented in urine (72% of the 11 patients), in sputum (19%), or at wound sites (9%). A total of 29 patients (66%) with infections due to MDR-GNB did not receive appropriate empirical antimicrobial therapy.
DISCUSSION
Gram-negative bacilli have a propensity to develop and acquire resistance to multiple antimicrobials [16] . In the present 6-year study, which focused on the epidemiology of MDR-GNB at hospital admission, a significant increase in the prevalence of MDR-GNB isolates recovered at admission was documented. By 2003, among isolates of gram-negative bacilli recovered from patients at hospital admission, 8%-13% of isolates were resistant to at least 3 antimicrobial groups. Although the majority of MDR-GNB isolates were resistant to 3 antimicrobial groups, 35% were resistant to 4 antimicrobial groups, and 12% were resistant to 5 antimicrobial groups. For example, 15% of MDR P. aeruginosa isolates were resistant to 5 antimicrobial groups, which included piperacillins, third-and fourth-generation cephalosporins, fluoroquinolones, and aminoglycosides. Of MDR Klebsiella species isolates, 20% were resistant to 5 antimicrobial groups, which included piperacillins, ceftazidime or cefepime, fluoroquinolones, and ampicillin/sulbactam. Three independent risk factors for harboring MDR-GNB at hospital admission were identified: older age (у65 years), exposure to antibiotics for у14 days during the 90 days before admission, and residence in a long-term care facility before admission. Antibiotic exposure may reflect endogenous acquisition of MDR-GNB from previously susceptible isolates [17] . However, eradication of normal gastrointestinal flora may also contribute to the emergence of MDR-GNB [18] . Because many patients who had MDR-GNB isolates recovered at hospital admission had a history of recurrent episodes of UTI or chronic skin ulcers, repetitive exposure to antibiotics in the treatment of these infections may have contributed to the emergence of antimicrobial resistance.
Although high rates of antimicrobial resistance among gramnegative bacilli and other pathogens have been documented among residents of long-term care facilities [19, 20] , the findings of the present study emphasize that residents of long-term care facilities contribute substantially to the influx of MDR-GNB into the hospital setting. To understand the implications of this finding requires insight into the dynamics of transmission of MDR-GNB in the hospital setting. Currently, the contribution of endogenous acquisition of MDR-GNB as a result of exposure to antibiotics and that of exogenous acquisition as a result of patient-to-patient transmission are not clear. A prospective study of colonization with ceftazidime-resistant gramnegative bacilli among patients in ICUs documented the emergence of resistance to ceftazidime substantially more frequently than exogenous acquisition resulting from patient-to-patient transmission through contaminated inanimate surfaces or health care workers [17, 21] . Although the study involving patients in ICUs suggests that antibiotic exposure may have a more prominent role in the emergence of resistance among gramnegative bacilli, several clonal outbreaks of MDR-GNB in hospitals and in long-term care facilities have been documented [22] [23] [24] , and, therefore, the contribution of horizontal transmission cannot be minimized.
In the present study, 29% of patients who harbored MDR-GNB had experienced previous colonization with VRE or MRSA. This finding reflects the commonality of previously documented risk factors for harboring antimicrobial-resistant bacteria [11] . It also emphasizes that infection-control interventions aimed at limiting the spread of antimicrobial-resistant pathogens could potentially be targeted to groups of patients with a high risk of harboring various antimicrobial-resistant pathogens, thereby minimizing the resources required.
A total of 66% of the patients with infection due to MDR-GNB at hospital admission did not receive empirical antimicrobial therapy with activity against MDR-GNB. Appropriate initial antibiotic treatment is crucial, given the high mortality rates associated with inappropriately treated infections due to gram-negative bacilli [25] [26] [27] . The substantial number of patients harboring MDR-GNB at hospital admission emphasizes the need for individual hospitals to explore common coresistance patterns among MDR-GNB.
The present study had several limitations. First, control pa- [28] . Second, in the present study, clinical cultures, rather than colonization status, were used to determine the presence or absence of MDR-GNB. The use of clinical cultures to identify MDR-GNB isolates as the outcome of interest may lead to the identification of factors associated with obtaining clinical cultures, irrespective of the presence of MDR-GNB. When analyzing risk factors for harboring antimicrobial-resistant bacteria, colonization status is the ideal outcome; however, the retrospective nature of the present study and the 6-year study period mitigated against the use of colonization status as the outcome. Third, molecular typing was not performed, and, therefore, the epidemiological relatedness of MDR-GNB strains was not assessed. However, the study institution is a large referral hospital, with case patients residing in different long-term care facilities or being transferred from different hospitals. Thus, it is unlikely that an outbreak in one of these health care settings could explain the steady increase in MDR-GNB isolates recovered during the 6-year study. Fourth, because this investigation was a large-scale surveillance study that spanned 6 years, the mechanisms of resistance-in particular, the presence of extended-spectrum blactamases-were not elucidated. However, the coresistance patterns noted among the E. coli and Klebsiella species isolates suggest that the majority were producers of extended-spectrum b-lactamase [29] . Last, the present study did not address the outcomes for patients with clinical culture results that were positive for MDR-GNB. These outcomes may differ substantially, depending on the site from which MDR-GNB isolates were recovered.
In conclusion, documentation of a substantial increase in the number of patients who harbor MDR-GNB at hospital admission, as well as the overall marked increase in MDR-GNB isolates among hospitalized patients [1, 30] , emphasizes the need to further our understanding of the dynamics of transmission of these antimicrobial-resistant pathogens. In particular, the contribution of cross-transmission versus the emergence of resistance from previously susceptible gram-negative isolates due to antimicrobial exposure needs to be further explored. If patient-to-patient transmission plays a prominent role in the dissemination of MDR-GNB, then this finding would require that emphasis be placed on the implementation of measures aimed at limiting horizontal spread of MDR-GNB. It may also warrant consideration of performing surveillance cultures, especially for high-risk patients (e.g., patients in long-term care facilities), to identify the unrecognized reservoirs of MDR-GNB. In contrast, if the rapid increase in MDR-GNB isolates is the result of endogenous acquisition, a focus on improving the judicious use of antimicrobials is required. Although there has been an abundance of studies focusing on the mechanisms of dissemination and the prevention of infections due to MRSA or VRE, the present study and other studies emphasize the urgent need to expand these investigations to include infections due to MDR-GNB.
